Skip to main content
Premium Trial:

Request an Annual Quote

In Brief This Week: Roche Molecular Diagnostics; Decode Genetics; Eurofins MWG Operon, Geospiza; Institut de Cancerologie Gustave Roussy; Genomics USA

NEW YORK (GenomeWeb News) – Roche Molecular Diagnostics this week said that its new Cobas p 630 Instrument has been launched with a CE Mark in Europe. The instrument is an automated, pre-analytical solution that is used with the firm's Amplilink 3.3 Series Software, which integrates the cobas p 630 with Roche's Cobas AmpliPrep Instruments and Cobas TaqMan Analyzers.

Decode Genetics has again raised the principal amount of a promissory note executed with Saga Investments. The firm said that the amount is now $3,820,000 and has a maturity date of Nov. 2, 2009. In early September, Decode initially executed the promissory note with Saga with a principal amount of $700,000, which had an interest rate of 8 percent per annum and was payable in full on Oct. 11, 2009. It has since increased the amount of the note several times.

Eurofins MWG Operon has selected Geospiza's GeneSifter Lab Edition software to manage its DNA sequencing systems, the firms said this week.

The Institut de Cancerologie Gustave Roussy (IGR) France announced today that its Genomic Center has been awarded ISO 9001 certification for quality management and compliance. IGR said that its center is the first academic Agilent-Certified Service Provider in the world to receive this certification. It noted that it also is a European Reference and Training Center for Agilent, running the complete portfolio of Agilent's microarray technologies.

Genomics USA said that it has been awarded a three-year, $2.52 million phase II continuation grant from the National Institute of Allergy and Infectious Diseases to support further development of its HLA chip for HLA typing for solid organ and stem cell transplantation. The Inverness, Ill.-based firm said that it also received a two-year, $600,000 phase I grant from NIAID to develop an AIDS chip.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.